Enhanced activation of prourokinase by human RC2A leukemia cells.
Tapiovaara
H
H
Department of Virology and Transplantation Laboratory, University of Helsinki, Finland.
Vaheri
A
A
Alitalo
R
R
Sim
P S
PS
Woodrow
G
G
Stephens
R W
RW
D002384:Catalysis; D003470:Culture Media; D004789:Enzyme Activation / Q000502:physiology; D004792:Enzyme Precursors / Q000378:metabolism*; D005341:Fibrinolysin / Q000378:metabolism; D006801:Humans; D007158:Immunologic Techniques; D007938:Leukemia / Q000201:enzymology*; D015849:Plasminogen Inactivators / Q000494:pharmacology; D011233:Precipitin Tests; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors / Q000378:metabolism; D055293:Receptors, Urokinase Plasminogen Activator; D011994:Recombinant Proteins / Q000494:pharmacology; D012697:Serine Endopeptidases / Q000378:metabolism; D014407:Tumor Cells, Cultured; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism*
D003470:Culture Media; D004792:Enzyme Precursors; C524898:PLAUR protein, human; D015849:Plasminogen Inactivators; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D011994:Recombinant Proteins; D012697:Serine Endopeptidases; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator